SPC
BSTC

Sigma Planning Corp’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Sigma Planning Corp’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,400
Closed -$263K – 1093
2019
Q2 		$263K Buy
+4,400
New +$277K 0.01% 797

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sigma Planning Corp's BSTC Position: Q3 2019 in Review

Sigma Planning Corp sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2019, closing a stake of 4,400 shares — an estimated $263K sold.

Sigma Planning Corp first reported a position in BSTC in Q2 2019 and held it in 1 quarter. The position peaked at $263K in Q2 2019. 114 funds tracked by Wall St. Rank hold BSTC as of Q3 2019.

  • Sigma Planning Corp reported no remaining BioSpecifics Technologies Corp. position as of Q3 2019 after selling out during the quarter.
  • Sigma Planning Corp sold 4,400 BioSpecifics Technologies Corp. shares in Q3 2019, an estimated $263K.
  • Sigma Planning Corp first reported a position in BioSpecifics Technologies Corp. in Q2 2019 and held it in 1 quarter.
  • Sigma Planning Corp's BioSpecifics Technologies Corp. position peaked at $263K in Q2 2019.
  • 114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2019.

Based on Sigma Planning Corp's 13F filing for Q3 2019, filed 1 Nov 2019.